The estimated Net Worth of Thierry Bernard is at least $16.8 mil dollars as of 15 September 2023. Mr. Bernard owns over 2,300 units of T2 Biosystems Inc stock worth over $16,841 and over the last 4 years he sold TTOO stock worth over $0. In addition, he makes $0 as Independent Director at T2 Biosystems Inc.
Sign up
Mr. Bernard TTOO stock SEC Form 4 insiders trading
Thierry has made over 6 trades of the T2 Biosystems Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 2,300 units of TTOO stock worth $5,290 on 15 September 2023.
The largest trade he's ever made was exercising 73,224 units of T2 Biosystems Inc stock on 25 June 2022 worth over $168,415. On average, Thierry trades about 15,524 units every 77 days since 2020. As of 15 September 2023 he still owns at least 7,322 units of T2 Biosystems Inc stock.
You can see the complete history of Mr. Bernard stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thierry Bernard biography
Thierry Bernard serves as Independent Director of the Company. Mr. Thierry Bernard is the CEO at QIAGEN. Mr. Bernard joined QIAGEN in February 2015 to lead QIAGEN's growing presence in molecular diagnostics. Mr. Bernard previously held multiple roles at bioMerieux for fifteen years, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region. Prior to joining bioMerieux, he served in management roles in multiple international environments. Mr. Bernard is a member of the Board of Directors of First Light Biosciences. He has earned degrees from Sciences Po (Paris), Harvard Business School, London School of Economics and the College of Europe, and is a member of French Foreign Trade Advisors.
How old is Thierry Bernard?
Thierry Bernard is 55, he's been the Independent Director of T2 Biosystems Inc since 2020. There are 11 older and 7 younger executives at T2 Biosystems Inc. The oldest executive at T2 Biosystems Inc is John Cumming, 74, who is the Lead Independent Director.
What's Thierry Bernard's mailing address?
Thierry's mailing address filed with the SEC is 101, Hartwell Avenue, Lexington, Middlesex County, Massachusetts, 02421, United States.
Insiders trading at T2 Biosystems Inc
Over the last 10 years, insiders at T2 Biosystems Inc have traded over $18,971,153 worth of T2 Biosystems Inc stock and bought 5,875,341 units worth $59,722,018 . The most active insiders traders include Adrian M Jones, Group L.P.Crg Partners Iii ... y Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of $764,499. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth $154.
What does T2 Biosystems Inc do?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
What does T2 Biosystems Inc's logo look like?
Complete history of Mr. Bernard stock trades at T2 Biosystems Inc
T2 Biosystems Inc executives and stock owners
T2 Biosystems Inc executives and other stock owners filed with the SEC include:
-
John McDonough,
Non-Executive Chairman of the Board -
Alec Barclay,
Chief Operating Officer -
John J. Sperzel III, B.Sc.,
Chairman & CEO -
Thomas Lowery,
Chief Scientific Officer -
Alec J. Barclay,
Chief Operations Officer -
Seymour Liebman,
Director -
David Elsbree,
Independent Director -
John Cumming,
Lead Independent Director -
Philip Taylor,
IR Contact Officer -
Robin Toft,
Independent Director -
Ninfa Saunders,
Independent Director -
Thierry Bernard,
Independent Director -
Anthony Pare,
Chief Commercial Officer -
Michael Gibbs,
Vice President, General Counsel -
John Sprague,
Chief Financial Officer -
John Sperzel,
President, Chief Executive Officer, Director -
Brett A. Giffin,
Chief Commercial Officer -
Dr. Aparna Jha Ahuja M.D.,
Chief Medical Officer -
Kelley J. Morgan,
Chief People Officer -
Michael Terrence Gibbs,
VP & Gen. Counsel -
John M. Sprague CPA,
Chief Financial Officer -
Aparna Ahuja,
Chief Medical Officer -
Brett A. Giffin,
Chief Commercial Officer -
Joanne Spadoro,
Chief Operations Officer -
Stanley Lapidus,
Director -
Rahul Dhanda,
SVP of Corporate Development -
Sachs Group Incgoldman Sach...,
-
Shawn Lynch,
Chief Financial Officer -
Joshua H. Bilenker,
Director -
David Harding,
Chief Commercial Officer -
Michael J. Cima,
Director -
Harry W Wilcox,
Director -
Group L.P.Crg Partners Iii ...,
-
Darlene M Deptula Hicks,
Chief Financial Officer -
Stanley N Lapidus,
Director -
Thomas J. Carella,
-
Michael A. Pfaller,
Chief Medical Officer -
Venture Partners V, L.P.Pol...,
-
Sarah O. Kalil,
Chief Operating Officer -
Maurice L Castonguay,
Chief Financial Officer -
Advisors, L.L.C. Mbd,
-
Venture Partners V, L.P.Pol...,
-
Sachs Group Incgoldman Sach...,
-
Alan L Crane,
Director -
Ventures Fund 2004 L P Flag...,
-
Capital Iii Lp Aisling Capi...,
-
Laura Lee Adams,
-
Adrian M Jones,
Director -
Sachs & Co. Llcgoldman Sach...,
-
Group L.P.Crg Partners Iii ...,